Two Sigma Investments, LP Takeda Pharmaceutical CO LTD Transaction History

Two Sigma Investments, LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	SELL	$13.36 - $15.43 $864,098 - $997,981	-64,678 Reduced 65.84%	33,550 $478,000
Q3 2023 Nov 14, 2023	BUY	$15.03 - $16.32 $27,279 - $29,620	1,815 Added 1.88%	98,228 $1.52 Million
Q1 2023 May 15, 2023	BUY	$15.28 - $16.48 $244,678 - $263,894	16,013 Added 19.92%	96,413 $1.59 Million
Q4 2022 Feb 14, 2023	BUY	$12.42 - $15.62 $998,568 - $1.26 Million	80,400 New	80,400 $1.26 Million
Q3 2020 Nov 16, 2020	SELL	$17.1 - $19.19 $723,757 - $812,216	-42,325 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$14.59 - $19.5 $617,521 - $825,337	42,325 New	42,325 $759,000
Q1 2020 May 15, 2020	SELL	$13.02 - $20.31 $1.2 Million - $1.88 Million	-92,370 Closed	0 $0
Q4 2019 Feb 14, 2020	BUY	$16.88 - $20.83 $1.56 Million - $1.92 Million	92,370 New	92,370 $1.82 Million

337

73.8M

1.96M

165K

Ticker TAK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 3,109,050,112
Market Cap $42.2B
Description
Takeda Pharmaceutical Company Limited engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan, the United States, Europe, Canada, Latin America, Russia, rest of Asia, and internationally. It offers pharmaceutical products in the areas of gastroenterology, rare diseases, plasma derived t...

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

Stay updated on Two Sigma Investments, LP with notifications on news.